Cargando…

Homologous and Heterologous Protection of Nonhuman Primates by Ebola and Sudan Virus-Like Particles

Filoviruses cause hemorrhagic fever resulting in significant morbidity and mortality in humans. Several vaccine platforms that include multiple virus-vectored approaches and virus-like particles (VLPs) have shown efficacy in nonhuman primates. Previous studies have shown protection of cynomolgus mac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Warfield, Kelly L., Dye, John M., Wells, Jay B., Unfer, Robert C., Holtsberg, Frederick W., Shulenin, Sergey, Vu, Hong, Swenson, Dana L., Bavari, Sina, Aman, M. Javad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368629/ https://www.ncbi.nlm.nih.gov/pubmed/25793502 http://dx.doi.org/10.1371/journal.pone.0118881

Ejemplares similares

Virus-Like Particle Vaccination Protects Nonhuman Primates from Lethal Aerosol Exposure with Marburgvirus (VLP Vaccination Protects Macaques against Aerosol Challenges)
por: Dye, John M., et al.
Publicado: (2016)

Euthanasia Assessment in Ebola Virus Infected Nonhuman Primates
por: Warren, Travis K., et al.
Publicado: (2014)

Post-exposure immunotherapy for two ebolaviruses and Marburg virus in nonhuman primates
por: Brannan, Jennifer M., et al.
Publicado: (2019)

Clinical Laboratory Values as Early Indicators of Ebola Virus Infection in Nonhuman Primates
por: Reisler, Ronald B., et al.
Publicado: (2017)

Role of Natural Killer Cells in Innate Protection against Lethal Ebola Virus Infection
por: Warfield, Kelly L., et al.
Publicado: (2004)

Gene-Specific Countermeasures against Ebola Virus Based on Antisense Phosphorodiamidate Morpholino Oligomers
por: Warfield, Kelly L, et al.
Publicado: (2006)

Evaluation in Nonhuman Primates of Vaccines against Ebola Virus
por: Geisbert, Thomas W., et al.
Publicado: (2002)

Characterization of the plasma proteome of nonhuman primates during Ebola virus disease or melioidosis: a host response comparison
por: Ward, Michael D., et al.
Publicado: (2019)

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp(™)
por: Qiu, Xiangguo, et al.
Publicado: (2014)

Natural history of nonhuman primates after conjunctival exposure to Ebola virus
por: Cross, Robert W., et al.
Publicado: (2023)

Comparative Transcriptomics in Ebola Makona-Infected Ferrets, Nonhuman Primates, and Humans
por: Cross, Robert W, et al.
Publicado: (2018)

Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding Site
por: Howell, Katie A., et al.
Publicado: (2016)

Oral and Conjunctival Exposure of Nonhuman Primates to Low Doses of Ebola Makona Virus
por: Mire, Chad E., et al.
Publicado: (2016)

Cytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infection
por: Marzi, Andrea, et al.
Publicado: (2016)

Atypical Ebola Virus Disease in a Nonhuman Primate following Monoclonal Antibody Treatment Is Associated with Glycoprotein Mutations within the Fusion Loop
por: Banadyga, Logan, et al.
Publicado: (2021)

Lipid nanoparticle siRNA treatment of Ebola virus Makona infected nonhuman primates
por: Thi, Emily P., et al.
Publicado: (2015)

Equine-Origin Immunoglobulin Fragments Protect Nonhuman Primates from Ebola Virus Disease
por: Wang, Hualei, et al.
Publicado: (2019)

Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate
por: Roozendaal, Ramon, et al.
Publicado: (2020)

Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus disease
por: Cross, Robert W., et al.
Publicado: (2022)

Nonhuman primate models of asthma
por: Coffman, Robert L., et al.
Publicado: (2005)

Radiographic Imaging of Nonhuman Primates
por: Celia R., Valverde, et al.
Publicado: (2005)

Nonhuman Primate Models for SARS
por: Haagmans, Bart L, et al.
Publicado: (2006)

Aging in nonhuman primates /
Publicado: (1979)

Behavior of Nonhuman Primates
por: Southwick, Charles H.
Publicado: (1966)

The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic fever
por: Rubins, Kathleen H, et al.
Publicado: (2007)

Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman Primates
por: Geisbert, Thomas W., et al.
Publicado: (2008)

Protective Efficacy of Neutralizing Monoclonal Antibodies in a Nonhuman Primate Model of Ebola Hemorrhagic Fever
por: Marzi, Andrea, et al.
Publicado: (2012)

Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb
por: Qiu, Xiangguo, et al.
Publicado: (2013)

Passive Immunotherapy: Assessment of Convalescent Serum Against Ebola Virus Makona Infection in Nonhuman Primates
por: Mire, Chad E., et al.
Publicado: (2016)

Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies
por: Madelain, Vincent, et al.
Publicado: (2018)

Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates
por: Pascal, Kristen E, et al.
Publicado: (2018)

Treatment of highly pathogenic filovirus infections using advanced antisense technology
por: Warren, Travis, et al.
Publicado: (2010)

Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate
por: Luke, Thomas, et al.
Publicado: (2018)

Coreceptor use in nonhuman primate models of HIV infection
por: Sina, Silvana Tasca, et al.
Publicado: (2011)

Assembly of Ebola Virus Matrix Protein VP40 Is Regulated by Latch-Like Properties of N and C Terminal Tails
por: Silva, Leslie P., et al.
Publicado: (2012)

Neuroanatomical asymmetries in nonhuman primates in the homologs to Broca's and Wernicke's areas: a mini-review
por: Hopkins, William D.
Publicado: (2022)

Discovering Drugs for the Treatment of Ebola Virus
por: Bixler, Sandra L., et al.
Publicado: (2017)

Distinct VSV-based Nipah virus vaccines expressing either glycoprotein G or fusion protein F provide homologous and heterologous protection in a nonhuman primate model
por: de Wit, Emmie, et al.
Publicado: (2022)

Multigenic DNA vaccine induces protective cross-reactive T cell responses against heterologous influenza virus in nonhuman primates
por: Koday, Merika T., et al.
Publicado: (2017)

Nonhuman primates in biomedical research /
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_0f252e8igk0mk3j0l603d21qqe